摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-diethyl-2-[2-(2-methyl-5-phenylpyrrol-1-yl)phenoxy]ethanamine;hydron;chloride

中文名称
——
中文别名
——
英文名称
N,N-diethyl-2-[2-(2-methyl-5-phenylpyrrol-1-yl)phenoxy]ethanamine;hydron;chloride
英文别名
——
N,N-diethyl-2-[2-(2-methyl-5-phenylpyrrol-1-yl)phenoxy]ethanamine;hydron;chloride化学式
CAS
——
化学式
C23H29ClN2O
mdl
——
分子量
384.9
InChiKey
JTOGCNWNXIHUHX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.6
  • 重原子数:
    27
  • 可旋转键数:
    8
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    17.4
  • 氢给体数:
    1
  • 氢受体数:
    2

文献信息

  • INLINE APPLICATION OF COATINGS
    申请人:Cook Medical Technologies LLC
    公开号:EP1993741B1
    公开(公告)日:2014-03-19
  • ZEIN COATED MEDICAL DEVICE
    申请人:Med Institute, Inc.
    公开号:EP1981560B1
    公开(公告)日:2010-09-08
  • Intraluminal device with a hollow structure
    申请人:Grewe D. David
    公开号:US20070043423A1
    公开(公告)日:2007-02-22
    Intraluminal devices are provided with an inner cavity. The inner cavity may be loaded with a bioactive substance. Fenestrations extend between an outer surface and the inner cavity. Thus, the bioactive substance may be released from the intraluminal device through the fenestrations.
  • Implantable medical device coatings with biodegradable elastomer and releasable therapeutic agent
    申请人:Ruane H. Patrick
    公开号:US20070196423A1
    公开(公告)日:2007-08-23
    A coated medical device, such as a stent, that elutes a therapeutic agent in a controlled manner is provided. The medical device may be coated with a layer of therapeutic agent and a layer of bioabsorbable elastomer over the layer of therapeutic agent. Methods of manufacturing a coated medical device and of coating a medical device are also provided.
  • Zein coated medical device
    申请人:Ruane H. Patrick
    公开号:US20070207183A1
    公开(公告)日:2007-09-06
    The invention relates to medical devices coated with zein. The medical device may include further a therapeutic agent in contact with zein. Zein allows the therapeutic agent to be retained on the device during delivery and also controls the elution rate of the therapeutic agent following implantation. The invention further relates to methods of delivering a therapeutic agent on said medical devices as well as their use especially in the form of stents for prevention of restenosis.
查看更多